Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma
This interventional, randomized, investigator blinded, controlled study conducted in one centre consists in a 4-month evaluation period within the same season avoiding sunny season on 140 subjects with facial epidermal melasma.
- EligibilityCriteria: Inclusion Criteria:  Facial epidermal melasma (exclude mixed and dermal melasma) Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face  Exclusion Criteria:  Subjects with any other signs of significant irritation or skin disease Subjects using oral contraceptive pills or hormonal implants as birth control measures during the study Subjects who had a skin lightening procedure in the past 8 weeks - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 20 Years - MaximumAge: 50 Years - StdAgeList: Adult